Author

Brian Gill

Columbia University Irving Medical Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:metabolomics· 1 Organism:mouse· 1

Frequent Co-Authors

Aayushi MahajaniD· 1 shared Abby L. Brand· 1 shared Allison Kleinstein· 1 shared Angeliki MelaiD· 1 shared Athanassios Dovas· 1 shared Brent R. StockwelliD· 1 shared Jeffrey N. BruceiD· 1 shared Jia GuoiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aayushi MahajanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

IDH-mutant inhibitors enhance the sensitivity of IDH1-mutant gliomas to cysteine-methionine deprivation and ferroptosis

Angeliki Mela, Abby L. Brand, Aayushi Mahajan, Athanassios Dovas, Nelson Humala, Smriti Kanangat, Allison Kleinstein, Sandra Leskinen, Trang Tt Nguyen, Qiuqiang Gao, Pavan S. Upadhyayula, Jia Guo, Brian Gill, Markus David Siegelin, Peter A. Sims, , Peter Canoll

This study shows that IDH1-mutant glioma cells are more sensitive to cysteine-methionine deprivation and ferroptosis inducers, and that IDH inhibitors enhance this sensitivity.

bioRxiv · Feb 2, 2026 · PreprintCancer Biology